CP 2008 v2 SN - WHO...79.0% 2007 600,404 472,405 23.3% 78.7% PreSAC/SAC 1,751,622 2006 MDA not...
6
1 COUNTRY P ROFILE PREVENTIVE CHEMOTHERAPY AND TRANSMISSION CONTROL DEPARTMENT OF CONTROL OF NEGLECTED TROPICAL DISEASES 2008 The control of neglected tropical diseases represents a major challenge to those providing health- care services in the endemic countries. The purpose of this country profile is to provide public health professionals with the most recently available epidemiological information on diseases for which a strategy and tools to implement large-scale preventive chemotherapy exist. This summary outlines the burden of targeted diseases and program implementation outcomes in Senegal . Senegal Source: Population data and population requiring PC for STH - United Nations, Population Division, The World Population Prospects - the 2008 revision, New York, 2009; Population requiring PC for LF - PELF; Population requiring PC for SCH - estimates based on L.Chitsulo et al. / Acta Tropica 77(2000)41-51; Population requiring PC for Oncho - APOC; Population requiring PC for Trachoma - ; School enrolment data - UNESCO Institute of Statistics, 2000 Assessment. 1 United Nations classification; 2 World Bank classification. BASIC COUNTRY DATA Total population 12,211,179 Population 1–4 years (Pre-SAC) 1,600,901 Population 5–14 years (SAC) 3,300,113 Population female 15–49 years 2,972,864 Population requiring preventive chemotherapy (PC) Lymphatic filariasis (LF) * 5,314,600 Schistosomiasis (SCH) * 10,150,100 Soil-transmitted helminthiasis (STH) * - Pre-SAC 1,600,901 - SAC 3,300,113 Onchocerciasis (Oncho) * 143,000 Trachoma Development status 1 LDC Income status 2 LIC School enrolment data Gross enrolment rate Girls enrolment ratio (gross) A FRICAN REGION The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2008. All rights reserved SITUATION ANALYSIS OF PREVENTIVE CHEMOTHERAPY DISEASES PCT disease Lymphatic filariasis Schistosomiasis Soil-transmitted helminthiasis Onchocerciasis Trachoma Loa-loa Endemicity status (endemic/non- endemic) Endemic Endemic Endemic Endemic Endemic Non-Endemic Disease distribution (Nationwide/ partial) Partial Nationwide Nationwide Partial Partial Mapping status (Complete/in progress/not done) Complete In progress In progress Complete Implementation status (Complete/in- progress/not done) In progress In progress In progress In progress * Provisional estimates, to be refined
Transcript of CP 2008 v2 SN - WHO...79.0% 2007 600,404 472,405 23.3% 78.7% PreSAC/SAC 1,751,622 2006 MDA not...
1
CO
UN
TRY P
RO
FILEPREVENTIVE CHEM
OTHERAPY AND TRANSM
ISSION CO
NTROL
DEPARTMENT O
F CONTRO
L OF NEG
LECTED TROPICAL DISEASES
2008SENEGAL
The control of neglected tropical diseases represents a major challenge to those providing health-care services in the endemic countries. The purpose of this country profile is to provide public healthprofessionals with the most recently available epidemiological information on diseases for which astrategy and tools to implement large-scale preventive chemotherapy exist.
This summary outlines the burden of targeted diseases and program implementation outcomes inSenegal.
Senegal
Source: Population data and population requiring PC for STH - United Nations, Population Division, The World PopulationProspects - the 2008 revision, New York, 2009; Population requiring PC for LF - PELF; Population requiring PC for SCH- estimates based on L.Chitsulo et al. / Acta Tropica 77(2000)41-51; Population requiring PC for Oncho - APOC;Population requiring PC for Trachoma - ; School enrolment data - UNESCO Institute of Statistics, 2000 Assessment.1 United Nations classification; 2 World Bank classification.
BASIC COUNTRY DATA
Total population 12,211,179Population 1–4 years (Pre-SAC) 1,600,901Population 5–14 years (SAC) 3,300,113Population female 15–49 years 2,972,864
Population requiring preventivechemotherapy (PC)Lymphatic filariasis (LF) * 5,314,600Schistosomiasis (SCH) * 10,150,100Soil-transmitted helminthiasis (STH) *
- Pre-SAC 1,600,901- SAC 3,300,113
Onchocerciasis (Oncho) * 143,000Trachoma
Development status1 LDCIncome status2 LIC
School enrolment dataGross enrolment rateGirls enrolment ratio (gross)
AFRICAN REGION
The boundaries and names shown and the designations used on this mapdo not imply the expression of any opinion whatsoever on the part of theWorld Health Organization concerning the legal status of any country,territory, city or area or of its authorities, or concerning the delimitationof its frontiers or boundaries. Dotted lines on maps represent approximateborder lines for which there may not yet be full agreement.© WHO 2008. All rights reserved
SITUATION ANALYSIS OF PREVENTIVE CHEMOTHERAPY DISEASES
PCT disease
Lymphatic filariasisSchistosomiasisSoil-transmittedhelminthiasisOnchocerciasisTrachomaLoa-loa
Endemicitystatus(endemic/non-endemic)
EndemicEndemicEndemic
EndemicEndemicNon-Endemic
Diseasedistribution(Nationwide/partial)
PartialNationwideNationwide
PartialPartial
Mapping status(Complete/inprogress/notdone)
CompleteIn progressIn progress
Complete
Implementationstatus(Complete/in-progress/not done)
In progressIn progressIn progress
In progress
* Provisional estimates, to be refined
2
CO
UN
TRY P
RO
FILE
PREV
ENTI
VE C
HEM
OTH
ERAP
Y AN
D TR
ANSM
ISSI
ON
CONT
ROL
DEP
ARTM
ENT
OF
CONT
ROL O
F NE
GLE
CTED
TRO
PICA
L DIS
EASE
S2008
SENEGAL
Maps of infection/disease endemicity
Sources: PELF; Integrated Plan of Action to control Helminthiasis and Trachoma in Senegal, MoH, 2006; National Programmeto control Schistosomiasis, MoH, 1999
Mali
Mauritania
GuineaGuinea-Bissau
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2009. All rights reserved
4
Endemicity of LFNon-endemicEndemic
Lymphatic filariasis
0 70 140 210 28035Kilometers
Mali
Mauritania
GuineaGuinea-Bissau
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2009. All rights reserved
4
Endemicity of OnchoNon-endemicEndemic
Onchocerciasis
0 70 140 210 28035Kilometers
Mali
Mauritania
GuineaGuinea-Bissau
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2009. All rights reserved
4
Prevalence of SCH_hLess than 10%>=10% and <50%50% and aboveNo data
Schistosimiasis, S. haematobium
0 70 140 210 28035Kilometers
Mali
Mauritania
GuineaGuinea-Bissau
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2009. All rights reserved
4
Prevalence of SCH_mNon-endemicLess than 10%>=10% and <50%50% and aboveNo data
Schistosimiasis, S. mansoni
0 70 140 210 28035Kilometers
Mali
Mauritania
GuineaGuinea-Bissau
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2009. All rights reserved
4
Less than 7%>=7% and <15%>=15% and <20%20% and aboveNo data
Trachoma
0 70 140 210 28035Kilometers
Prevalence of Trachoma(children lessthan 10 years old)
Mali
Mauritania
GuineaGuinea-Bissau
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2009. All rights reserved
4
Prevalence of STHLess than 20%>=20% and <50%50% and aboveEndemic areas
Soil-transmitted helminthiasis
0 70 140 210 28035Kilometers
but prevalencedata is not available
3
CO
UN
TRY P
RO
FILEPREVENTIVE CHEM
OTHERAPY AND TRANSM
ISSION CO
NTROL
DEPARTMENT O
F CONTRO
L OF NEG
LECTED TROPICAL DISEASES
2008SENEGAL
Maps of preventive chemotherapy strategy required
MDA1 (IVM+ALB), MDA2 (DEC+ALB), MDA3 (IVM), T1 (ALB or MBD + PZQ), T2 (PZQ), T3 (ALB or MBD)
Mali
Mauritania
GuineaGuinea-Bissau
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2009. All rights reserved
4
ROUND 1AZTMDA1MDA1 and AZTMDA3
0 70 140 210 28035Kilometers
PC strategy required - ROUND 1
Mali
Mauritania
GuineaGuinea-Bissau
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ' WHO 2009. All rights reserved
4
ROUND 2No impl./No dataT1T2 once in two years
0 70 140 210 28035Kilometers
PC strategy required - ROUND 2
4
CO
UN
TRY P
RO
FILE
PREV
ENTI
VE C
HEM
OTH
ERAP
Y AN
D TR
ANSM
ISSI
ON
CONT
ROL
DEP
ARTM
ENT
OF
CONT
ROL O
F NE
GLE
CTED
TRO
PICA
L DIS
EASE
S2008
SENEGAL
Preventive chemotherapy implementation
PREVENTIVE CHEMOTHERAPY IMPLEMENTATION
MDA1 (IVM + ALB)Population targetedPopulation treatedGeographical coverageProgramme coverage
MDA2 (DEC + ALB)Population targetedPopulation treatedGeographical coverageProgramme coverage
MDA3 (IVM)Population targetedPopulation treatedGeographical coverageProgramme coverage
T1 (ALB or MBD + PZQ)Population targetedPopulation treatedGeographical coverageProgramme coverage
T2 (PZQ)Population targetedPopulation treatedGeographical coverageProgramme coverage
T3 (ALB or MBD)Population targetedPopulation treatedGeographical coverageProgramme coverage
T1 (ALB or MBD + PZQ)Population targetedPopulation treatedGeographical coverageProgramme coverage
T2 (PZQ)Population targetedPopulation treatedGeographical coverageProgramme coverage
T3 (ALB or MBD)Population targetedPopulation treatedGeographical coverageProgramme coverage
20092008
594,346447,59321.2%75.3%
143,000112,97081.8%79.0%
2007
600,404472,40523.3%78.7%
PreSAC/SAC
1,751,622
2006
MDAnot started
SAC
10,402
PreSAC/SAC
1,805,665
2010R
OU
ND
1R
OU
ND
2
Geographical coverage - proportion (%) of endemic districts covered with preventive chemotherapy;Programme coverage - proportion (%) of individuals who were treated as per the programme target.
NOT REQUIRED
NOT REQUIRED
NOT REQUIRED
NOT REQUIRED
NOT REQUIRED
NOT REQUIRED
5
CO
UN
TRY P
RO
FILEPREVENTIVE CHEM
OTHERAPY AND TRANSM
ISSION CO
NTROL
DEPARTMENT O
F CONTRO
L OF NEG
LECTED TROPICAL DISEASES
2008SENEGAL
National disease-specific coverage
Pre-SAC SAC
POPULATION AT-RISK OF ONCHOAND TREATED BY DEWORMING
LYMPHATIC FILARIASIS SCHISTOSOMIASIS *
SOIL-TRANSMITTED HELMINTHIASIS
ONCHOCERCIASIS
0.0
0.5
1.0
1.5
2.0
2003 2004 2005 2006 2007 2008
Mill
ions
0%20%40%60%80%100%120%140%
Requiring PCTreatedNational coverage
0.00.51.01.52.02.53.03.5
2003 2004 2005 2006 2007 2008
Mill
ions
0%
5%
10%
15%
20%
Requiring PCTreatedNational coverage
0
1
2
3
4
5
6
2007 2008
Mill
ions
0%
5%
10%
15%
20%
Requiring PCTreatedNational coverage
0.0
0.5
1.0
1.5
2.0
2.5
3.0
2006
Mill
ions
0%
1%
2%
3%
4%
5%
Requiring PCTreatedNational coverage
TRACHOMA
* SAC
No data available
National disease-specific coverage - proportion (%) of individuals in the population requiring preventivechemotherapy for the specific disease (see Basic country data on page 1) that have been treated.
** Number of people treated via LF programme (MDA1) is not included in this chart.
0
40
80
120
160
2008
Thou
sand
s
0%
20%
40%
60%
80%
100%
Requiring PCTreatedNational coverage
6
CO
UN
TRY P
RO
FILE
PREV
ENTI
VE C
HEM
OTH
ERAP
Y AN
D TR
ANSM
ISSI
ON
CONT
ROL
DEP
ARTM
ENT
OF
CONT
ROL O
F NE
GLE
CTED
TRO
PICA
L DIS
EASE
S2008
SENEGAL
Monitoring decline of disease endemicity(in sentinel sites or periodic surveys)
LYMPHATIC FILARIASIS
Cumulative number of SS with base line mf>1% identified(of total)Percent of the SS (with a baseline of >1%) which haveMf prev <1% in yearNo. of IUs where MDA discontinued after meetingepidemiological criteria
Years ->
Data source:
SOIL-TRANSMITTED HELMINTHIASIS
Years ->
STH prevalence in pre-SAC (range)STH prevalence in SAC (range)
Data source:
SCHISTOSOMIASIS
Years ->
S. haematobium prevalence (range)S. mansoni prevalence (range)
Data source:
ONCHOCERCIASIS
Years ->
Number of endemic communitiesNumber of endemic communities with baseline >1%Number of endemic communities discontinued aftermeeting epidemiological criteria
Data source:
TRACHOMA
Data source:
Years ->
TF/TI ratio in 1-9 years oldTrachomatous trichiasis males & females > 30 years oldDistricts achieving Ultimate Intervention Goals, %“CHANCE” at least 80%
For more detailed information, please contact:
Preventive Chemotherapy and Transmission Control, Department of Control of Neglected Tropical DiseasesWorld Health Organization, 20, avenue Appia, 1211 Geneva 27, Switzerland
We would also like to be informed as soon as possible if we have made any errors in detailing your activities orif you have any other comments. Thank you for your collaboration.
Our contact e-mail is [email protected]
© World Health Organization 2009. All rights reserved. This document is not a formal publication of WHOand does not necessarily represent the decisions or the stated policy of the Organization. The presentation ofmaps contained herein does not imply the expression of any opinion whatwoever on the part of WHOconcerning the legal status of any country, territory, city or area or of its authorities, or concerning thedelineation of its frontiers or boundaries.
